Labshake search
Citations for Biomedical Polymers :
1 - 26 of 26 citations for Recombinant Human dipeptidyl peptidase 4 since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Immunology 2023Quote: ... 10 ng/mL recombinant human Bone Morphogenetic Protein 4 (BMP-4), 5 ng/mL human FGF-basic (154 a.a.) ...
-
bioRxiv - Developmental Biology 2020Quote: ... Treatments with recombinant BMP2/4 (Recombinant Mouse BMP-4 Protein, CF 5020-BP/CF) or Nodal (Recombinant human Nodal protein 3218-ND-025/CF ...
-
bioRxiv - Bioengineering 2023Quote: ... Recombinant human bone morphogenetic protein-2 (BMP-2) and the human BMP-2 DuoSet enzyme-linked immunosorbent assay (ELISA ...
-
bioRxiv - Developmental Biology 2021Quote: ... ELISA kits were purchased from Abcam (human BMP-4 and CGβ) and Proteintech (human GDF15) ...
-
bioRxiv - Cancer Biology 2023Quote: ... the FGF and EGF mitogens in the media were replaced by 100 ng/ml of BMP4 (Recombinant human BMP-4, PeproTech, Cat# AF-120-05ET) (quiescence media) ...
-
bioRxiv - Bioengineering 2019Quote: ... Defects were either treated with 2 µg recombinant human bone morphogenetic protein 2 (BMP-2, Pfizer), delivered via a hybrid biomaterial scaffold described below consisting of 120 µL BMP-2-laden alginate hydrogel injected inside an electrospun polycaprolactone (PCL ...
-
bioRxiv - Microbiology 2020Quote: ... in the presence of SFD containing either a combination of five factors (3 μM CHIR99021, 10 ng/ml human FGF10, 10 ng/ml human FGF7, 10 ng/ml human BMP-4, and 50 nM ATRA), or three factors (3 μM CHIR99021 ...
-
bioRxiv - Bioengineering 2020Quote: ... Defects in both studies were acutely treated with a minimal healing dose of recombinant human bone morphogenetic protein 2 (BMP-2) delivered via a hybrid RGD-alginate/PCL biomaterial platform described in detail previously30,31 ...
-
bioRxiv - Bioengineering 2019Quote: ... 2013] consisting of the osteogenic media supplemented with 100 ng/mL BMP-2 (recombinant human BMP-2, 355-BM-050, R&D Systems). Media was replaced every 3 days ...
-
bioRxiv - Cell Biology 2022Quote: Confluent HUAEC cells in EC specific medium with 2% FBS were treated with 2 ng/ml BMP9 (Recombinant Human BMP-9 Protein, # 3209-BP, R&D®) and proteins extracted at specified time points after treatment ...
-
bioRxiv - Bioengineering 2020Quote: ... bone morphogenetic protein 4 (BMP-4, 6.7 ng/mL; Peprotech), human interleukin 3 (hIL-3 ...
-
bioRxiv - Developmental Biology 2019Quote: ... + 10 ng/mL Bone Morphogenetic Protein-4 (BMP-4, PromoKine) + 0.3 mg/mL retinoic acid (RA ...
-
bioRxiv - Cell Biology 2022Quote: ... and 10 ng/mL bone morphogenetic protein 4 (BMP-4) (R&D System ...
-
bioRxiv - Developmental Biology 2022Quote: ... containing 25 ng/ml bone morphogenetic protein-4 (BMP-4, R&D Systems) and 1 μM all-trans Retinoid Acid (RA ...
-
bioRxiv - Bioengineering 2022Quote: ... The cells were then cultured with bone morphogenic protein-4 (BMP-4; R&D Systems) and CHIR-99021 in RPMI-B27 medium to specify for cardiac mesoderm lineages ...
-
bioRxiv - Neuroscience 2023Quote: ... which consisted of mTESR1 supplemented with bone morphogenetic protein 4 (BMP-4, 50 ng/ml), stem cell factor (SCF ...
-
bioRxiv - Immunology 2021Quote: ... iPSCs were harvested and plated into Essential 8 Flex medium supplemented with 50ng/ml bone morphogenetic protein 4 (BMP-4; Bio-Techne), 20ng/ml stem cell factor (SCF ...
-
bioRxiv - Bioengineering 2023Quote: ... Each scaffold type was n = 4 per group (Uncoated, BMP-2 only (or Delayed Laponite/BMP-2 in the second study) ...
-
bioRxiv - Cell Biology 2021Quote: ... gene expression was analysed using the TaqMan™ Array Human Cardiomyocyte Differentiation by BMP Receptors (Thermo Fisher Scientific ...
-
bioRxiv - Cell Biology 2020Quote: ... cells were expanded in EM for 4 days and subsequently stimulated with 10 ng/ml bone morphogenetic protein (BMP) 9 (BioLegend ...
-
bioRxiv - Neuroscience 2022Quote: ... in 100 μl embryoid body medium (10 mM ROCK inhibitor, 50 ng/mL BMP-4 (Peprotech; Cat. No. 120-05), 20 ng/mL SCF (Peprotech ...
-
bioRxiv - Bioengineering 2023Quote: ... Each scaffold type was n = 4 per group (Uncoated, BMP-2 only (or Delayed Laponite/BMP-2 in the second study), Laponite/BMP-2 coated or collagen sponge/BMP-2) ...
-
bioRxiv - Developmental Biology 2023Quote: ... under accession codes GSExxxxxx (FOXA2+ vs FOXA2- cells at Day 5, Figure 3) and GSExxxxxx (FOXA2+ vs FOXA2- cells after BMP perturbations, Figure 4).
-
bioRxiv - Bioengineering 2023Quote: ... The in vivo subcutaneous implantation study samples were n = 4 biological samples for each scaffold type (Laponite/BMP-2 or BMP-2 only coated) with each sample plated out in triplicate wells and the average result of each scaffold triplicate was used for statistical analysis.
-
bioRxiv - Bioengineering 2023Quote: ... The in vivo subcutaneous implantation study samples were n = 4 biological samples for each scaffold type (Laponite/BMP-2 or BMP-2 only coated) with each sample plated out in triplicate wells and the average result of each scaffold triplicate was used for statistical analysis.
-
bioRxiv - Genomics 2021Quote: ... collected and plated at 10,000 per well in 96-well ultra-low attachment plates in 100 mL embryoid body medium (10 mM ROCK inhibitor, 50 ng/mL BMP-4 (Peprotech; Cat. No. 120-05), 20 ng/mL SCF (Peprotech ...